Ryan K. Shields
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria 104
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance 36
- Pharmacology top 0.1%
- Antibiotics Pharmacokinetics and Efficacy 93
- Endocrinology top 0.5%
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 22
-
- Antifungal resistance and susceptibility 42
- Antimicrobial Resistance in Staphylococcus 24
-
- Pneumonia and Respiratory Infections 26
- Pneumocystis jirovecii pneumonia detection and treatment 25
- Co-authors
- Cornelius J. ClancyM. Hong NguyenEllen G. PressYohei DoiBarry N. KreiswirthLiang ChenBrian A. PotoskiBinghua Hao
- Journals
- Antimicrobial Agents and Chemotherapy (55 papers)Open Forum Infectious Diseases (31 papers)Clinical Infectious Diseases (24 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Ryan K. Shields
183 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Medicine 4.7k
- Applied Microbiology and Biotechnology 1.6k
- Pharmacology 3.3k
- Endocrinology 921
- Clinical Biochemistry 825
Countries citing papers authored by Ryan K. Shields
This map shows the geographic impact of Ryan K. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan K. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan K. Shields more than expected).
Fields of papers citing papers by Ryan K. Shields
This network shows the impact of papers produced by Ryan K. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan K. Shields. The network helps show where Ryan K. Shields may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryan K. Shields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 16 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 10 | |
| 14 | 2021 | 24 | |
| 15 | 2020 | 23 | |
| 16 | 2017 | 40 | |
| 17 | Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infectionsbreakdown → | 2016 | 393 |
| 18 | 2014 | 54 | |
| 19 | 2014 | 46 | |
| 20 | 2013 | 89 |
About Ryan K. Shields
Ryan K. Shields is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Endocrinology and Infectious Diseases, having authored 199 papers that have together received 7.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (104 papers), Antibiotics Pharmacokinetics and Efficacy (93 papers), Antifungal resistance and susceptibility (42 papers), Antibiotic Use and Resistance (36 papers), Pneumonia and Respiratory Infections (26 papers), Pneumocystis jirovecii pneumonia detection and treatment (25 papers), Antimicrobial Resistance in Staphylococcus (24 papers) and Bacterial Identification and Susceptibility Testing (22 papers). The work is most often cited by research in Molecular Medicine (4.7k citations), Applied Microbiology and Biotechnology (1.6k citations), Pharmacology (3.3k citations), Endocrinology (921 citations) and Clinical Biochemistry (825 citations). Ryan K. Shields has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Cornelius J. Clancy, M. Hong Nguyen, Ellen G. Press, Yohei Doi, Barry N. Kreiswirth, Liang Chen, M. Hong Nguyen, Brian A. Potoski, Binghua Hao and Shaoji Cheng. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and The Journal of Heart and Lung Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.